+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biopharmaceuticals Market Research Reports

SYNAGIS Market Size, Forecast, and Market Insight - 2032 - Product Thumbnail Image

SYNAGIS Market Size, Forecast, and Market Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
mRNA-1345 Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

mRNA-1345 Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
ABRYSVO Market Size, Forecast, and Market Insight - 2032 - Product Thumbnail Image

ABRYSVO Market Size, Forecast, and Market Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
MEDI8897 Market Size, Forecast, and Market Insight - 2032 - Product Thumbnail Image

MEDI8897 Market Size, Forecast, and Market Insight - 2032

  • Report
  • February 2024
  • 30 Pages
  • Global
From
Generic And Biosimilar Pharmaceuticals - Global Industry Report - Product Thumbnail Image

Generic And Biosimilar Pharmaceuticals - Global Industry Report

  • Report
  • November 2024
  • 1130 Pages
  • Global
From
Vaccine Manufacturers - Industry Report - Product Thumbnail Image

Vaccine Manufacturers - Industry Report

  • Report
  • October 2024
  • 83 Pages
  • Global
From
Generic and Biosimilar Pharmaceuticals - Industry Report - Product Thumbnail Image

Generic and Biosimilar Pharmaceuticals - Industry Report

  • Report
  • October 2024
  • 2285 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
From
From
From
Loading Indicator

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders. Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively. Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more